Navigation Links
Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
Date:10/29/2009

BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received purchase orders for its MammoView(TM) line of surgical endoscopy instruments from University of California, San Diego Medical Center, San Diego California. UCSD Medical Center is highly regarded in the industry as it provides a significant amount of healthcare in San Diego. UCSD Medical Center operates a network of outpatient practices, free clinics and community-based services.

UCSD Medical Center was named among the best in the nation in six specialty areas, in addition to possessing eighty physicians who earned a place in San Diego Magazine's 2009 "Physicians of Exceptional Excellence." UCSD Medical Center is home to one of just 39 National Cancer Institute-designated Comprehensive Cancer Centers in the United States. Such centers are prominent among the leading institutions in the nation dedicated to scientific innovation and clinical excellence. UCSD is the only Comprehensive Cancer Center in San Diego and Imperial counties to have earned this honor.

"We are extremely pleased to be a supplier to such a distinguished medical institution that is one of the top health care providers in the United States. We believe that our MammoView line will be instrumental in serving UCSD Medical Center wellness initiatives," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its FDA approved MammoView(TM) line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.

For more information on UCSD Medical Center, please visit: www.ucsd.edu

About Solos Endoscopy, Inc.:

Solo
'/>"/>

SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView(TM) Product Line
2. Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line
3. Solos Endoscopy, Inc.s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
4. Solos Endoscopy, Inc.s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
5. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
6. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
7. Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair(R) System for Severe Asthma
8. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
9. Lumenis Receives 510K Clearance for the PolyScope Disposable Flexible Endoscope
10. Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
11. Pharmalink AB Receives Patent for Nefecon(R) Principle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK, Aug 20, 2014 Reportlinker.com ... available in its catalogue: Global Patient ... This report analyzes the worldwide markets ... following Product Segments: Floor Scales, Infant & Baby ... report provides separate comprehensive analytics for the US, ...
(Date:8/19/2014)... 2014   Lincor Inc. today announced ... to New Jersey -based healthcare ... Health will deploy Lincor,s PatientLINC technology across its ... and Hoboken University Medical Center. Lincor,s ... solutions to help hospitals reach new levels of ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder ... present a scientific poster describing an innovative diagnostic procedure ... 2014: Shedding New Light on Disease (SPEC) conference in ... Dr. Treado,s poster entitled, "Development of in vitro Diagnostics ... will be discussed during the conference poster session on ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2
... Claron Technology makes the PROFIT 200 list for ... developer Claron Technology, headquartered in Toronto, has been included ... Fastest-Growing Companies by PROFIT Magazine. Ranking Canada,s Fastest-Growing Companies ... country,s most successful growth companies. Published in the Summer ...
... a medical technology company developing a platform of endoscopically ... obesity and type 2 diabetes, announced today the completion ... led by Broadline Capital, a global private equity investment ... issued and pending patents, will use the funding to ...
Cached Medicine Technology:Claron Technology Makes the PROFIT 200 List for the Third Consecutive Year 2EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital 2
(Date:8/20/2014)... Gray HealthDay Reporter WEDNESDAY, ... rare, colds, flu and other minor infections might trigger a ... children, a new study suggests. Just five out of ... States, said Dr. Heather Fullerton, lead author of the study ... of California, San Francisco Benioff Children,s Hospital. "It seems infections ...
(Date:8/20/2014)... Doheny HealthDay Reporter WEDNESDAY, ... mastectomy has long been an option, but a new study ... "The most common reasons women didn,t undergo reconstruction was ... more surgery or they were focused on their cancer treatment," ... at Memorial Sloan Kettering Cancer Center, in New York City. ...
(Date:8/20/2014)... common approach to treating kidney failure by removing waste ... for people who suddenly developed the condition, in an ... School of Medicine. , Their findings, published online in ... an aggressive method that is standardly used for people ... benefit to the patient. , "Our findings question the ...
(Date:8/20/2014)... cancer - using Botox. A study presented in the ... shows that cancer growth could be suppressed by eliminating ... cancer stem cells. The approach thus treated the cancer. ... and efficient. The researchers have thus far tested the ... humans. , The nervous system is crucial in regulating ...
(Date:8/20/2014)... August 20, 2014 A common approach ... the blood did not improve survival chances for people ... by experts at the University of Pittsburgh School ... today in the journal PLOS One , suggest ... for people with sudden kidney failure, may not provide ...
Breaking Medicine News(10 mins):Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Treating gastric cancer -- with Botox 2Health News:Pitt Analysis Questions Use of Acute Hemodialysis Treatment 2
... efforts beginning as evacuees leave coastal areas, WASHINGTON, ... Gulf Coast states, the American Red Cross is starting ... Red Cross has relief,operations ready in four states: Alabama, ... storm is urged to prepare, listen to officials,and heed ...
... release is available in Spanish . ... psychiatric diseases, often associated with considerable treatment needs and ... and family (Pini et al., 2005). Previously also labelled ... an episodic, yet lifelong and clinically severe mood (or ...
... found telmisartan offered slight benefit for those unable to ... -- A new study offers a possible alternative to ... blood pressure under control but who cannot tolerate the ... European Society of Cardiology in Munich on Sunday, Canadian ...
... August 31, 2008 -- An international study led by ... to lower blood pressure, reduced the outcome of cardiovascular ... unable to tolerate a widely available and effective standard ... in the Michael G. DeGroote School of Medicine at ...
... Aug. 31, 2008 Many nursing mothers who ... the "superbug" methicillin-resistant Staphylococcus aureus , or MRSA, ... Center physicians, conservative treatment can deal with the problem. ... mastitis, and showed that MRSA was much more likely ...
... Council (ACC) applauds the California Assembly for listening ... bill that would have,needlessly removed safe and essential ... containing bisphenol A has been recently,reaffirmed by scientific ... legislators made the right decision for their consumers,",stated ...
Cached Medicine News:Health News:American Red Cross Relief Efforts Underway for Gustav 2Health News:The ECNP consensus statement on bipolar depression 2Health News:The ECNP consensus statement on bipolar depression 3Health News:The ECNP consensus statement on bipolar depression 4Health News:The ECNP consensus statement on bipolar depression 5Health News:Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics 2Health News:Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke 2Health News:'Superbug' breast infections controllable in nursing mothers, UT Southwestern researchers find 2Health News:ACC Applauds California's Decision to Not Ban Food-Contact Products Containing Bisphenol A 2
... enzyme-linked immunosorbent assay for the ... IgG-class antibodies to Gliadin in ... intended to be used as ... of gastrointestinal disorders, mainly Coeliac ...
... assurance reagent in assays detecting IgG and IgM ... IgM), IgG and IgM antibodies to rubella virus ... antibodies to cytomegalovirus (CMV IgG and IgM), and ... types 1 and 2 (HSV-1 IgG, HSV-1 IgM, ...
... The Titan Procedure is a ... infrared light source to tighten skin ... The Titan heats the dermis to ... epidermis through continuous cooling. In addition, ...
... XLTEK lets you choose how to configure your ... the study to be performed we recommend ... your budget and clinical needs. How do we ... listen. The result? Kortex. The system that lets ...
Medicine Products: